Zárate-Aspiros R, Rosas-Sumano AB, Sánchez-Ramírez AR, Trujillo-Martínez G

Language: Spanish
References: 24
Page: 39-42
PDF size: 184.66 Kb.

ABSTRACT

Methemoglobinemia is a condition in which there are high blood levels of methemoglobin. It may be congenital or acquired. The congenital form (which is rare) is the result of a defect in the methemoglobin reductase enzyme, dependent of the nicotinamide adenine dinucleotide phosphate reduced (NADPH); it is also caused by hemoglobinopathies. Congenital methemoglobinemia type 2 constitutes 10% of all cases and is usually fatal in early life. Its main feature is progressive neurological deterioration associated with mental retardation, microcephaly, opisthotonos, athetotic movements, and generalized hypertonia. We report the case of a newborn with cyanosis from birth in whom perinatal hypoxia, pulmonary disease, heart failure and sepsis were ruled out, hence methemoglobin levels were requested, which led to the diagnosis of congenital methemoglobinemia based on a methemoglobin of 29.6%. Methemoglobin values were investigated in his 2 years old brother, who was cyanotic and showed progressive psychomotor retardation from birth; his methemoglobin was 30%. We concluded that both patients had type 2 hereditary methemoglobinemia in view of the severe neurological disorders of the older brother. Treatment with ascorbic acid was initiated in both siblings, resulting in the disappearance of cyanosis in the newborn.

REFERENCES

1. Prevalence of rare diseases : Bibliographic data, Informes periódicos de Orphanet, serie Enfermedades Raras. Mayo 2011,Número 1: lista por orden alfabético de enfermedades. http://www.orpha.net/orphacom/cahiers/docs/ES/Prevalencia_de_las_enfermedades_raras_por_orden_alfabetico.pdf

2. Toelle SP, Boltshauser E, Mössner E, Zurbriggen K, Eber S. Severe neurological impairment in hereditary methemoglobinaemia type 2. Eur J Pediatr 2004;163(4-5):207-9.

3. Kedar PS, Colah RB, Ghosh K, Mohanty D. Congenital methemoglobinemia due to NADH-methemoglobin reductase deficiency in three Indian families. Haematologia (Budap) 2002;32(4):543-9.

4. Yüksel D, Senbil N, Yilmaz D, Yarali N, Gürer YK. A rare cause of mental motor retardation: recessive congenital methemoglobinemia type II. Turk J Pediatr 2009;51(2):187-9.

5. Schwartz L, Franck P, Debruille C, Olivier JL, Vigneron C. Congenital methemoglobinaemia: a rare case of cyanosis in the newborn. Ann Biol Clin (Paris) 2005;63(3):314-6.

6. Smith B, Pryds OA, Christensen E, Lund AM. Congenital methemoglobinaemia: an infrequent cause of neonatal cyanosis. Ugeskr Laeger 2008;170(33):2460-1.

7. De Rubens-Figueroa J, Jiménez-González M, Francisco-Revilla E. Cianosis como manifestación de metahemoglobinemia. Rev Med Inst Mex Seguro Soc 2008;46(4):439- 44.

8. Da-Silva SS, Sajan IS, Underwood JP III. Congenital methemoglobinemia: a rare cause of cyanosis in the newborn—a case report. Pediatrics 2003;112:e158–61.

9. Nelson, Kliegman, Behrman. Metahemoglobinemia Hereditaria. Tratado de Pediatria Volumen II. 18a ed. España: Elsevier Saunders; 2009. p. 2032-3.

10. Ewenczyk C, Leroux A, Roubergue A, Laugel V, Afenjar A, Saudubray JM, et al . Recessive hereditary methemoglobinaemia, type II: delineation of the clinical spectrum. Brain 2008;131:760-71.

11. Salinas JA, Corral H, Guibelalde M, De Carlos JC, Hernández I. Metahemoglobinemia. Causa de cianosis en el niño. Acta Pediatr Esp 2010;68(3):143-5.

12. Di Maio AM, Singh J. El lactante cianótico en la sala de urgencias. Medicina Pediátrica de urgencias. Clínicas pediátricas de Norteamérica Vol.5. 1a ed español. Interamericana; 1992. p. 1095-111.

13. Francois. Cas de cyanose congeniale sans cause apparente. Bull Acad Roy Med Belg 1845;4:698.

14. Gibson QH. The reduction of methemoglobin by ascorbic acid. Biochem J 1943;37:615-8.

15. Gibson QH. The reduction of methemoglobin in red blood cells and studies on the cause of idiopathic methemoglobinemia. Biochem J 1948;42:13-23.

16. Scott EM, Griffith IV. The enzyme defect of hereditary methemoglobinemia: diaphorase. Biochim Biophys Acta 1959;34:584–6.

17. Fisher RA, Povey S, Bobrow M, Solomon E, Boyd Y, Carritt B.Assignment of the DIA1 locus to chromosome 22. Ann Hum Genet 1977; 41: 151–5.

18. Jaffe ER. Enzymopenic hereditary methemoglobinemia: a clinical/biochemical classification. Blood Cells 1986;12:81–90.

19. Jaffe ER, Hultquist DE. Cytochrome b5 reductase deficiency and enzymopenic hereditary methemoglobinemia. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The Metabolic and Molecular Basis of Inherited Disease. 7th ed. New York, NY: McGraw-Hill; 1995. p. 2267–80

20. Worster-Drought C, White JC, Sargent F. Familial idiopathic methemoglobinemia associated with mental deficiency and neurologic abnormalities. Br Med J 1953;2:114–8.

21. Leroux A, Junien C, Kaplan J. Generalized deficiency of cytochrome b5 reductase in congenital methemoglobinemia with mental retardation. Nature 1975;258:619–20.

22. Hirono H. Lipids of myelin, white matter and gray matter in a case of generalized deficiency of cytochrome b5 reductase in congenital methemoglobinemia with mental retardation. Lipids 1980;15:272–5.

23. Nagai T, Shirabe K, Yubisui T. Analysis of mutant NADH cytochrome b5 reductase: apparent type III can be explained as type I with an unstable reductase. Blood 1993;81:808–14.

24. Hegesh E, Hegesh J, Kaftory A. Congenital methemoglobinemia with a deficiency of cytochrome b5. N Engl J Med 1986;314:757–61.